POSTERS ASCO 2024

Melanoma y cánceres de piel

ADU-1604, a novel CTLA-4 blocking antibody, to modulate pharmacodynamic markers in patients with PD1 relapse/refractory melanoma.

ADU-1604, a novel CTLA-4 blocking antibody, to modulate pharmacodynamic markers in patients with PD1 relapse/refractory melanoma.

Abstract: 9552 Poster Bd #: 336

Poster

Descargar

Autor
Guillermo De Velasco, PhD

Oncólogo Médico del Servicio de Oncología del Hospital Ruber Internacional

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON